Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Ana Berrio"'
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundPimavanserin, a selective 5-HT2A inverse agonist/antagonist, is the only treatment approved by the US Food and Drug Administration for hallucinations and delusions associated with Parkinson's disease (PD) psychosis.AimWe aimed to evaluate m
Externí odkaz:
https://doaj.org/article/895728bd476845e8ab214aa5f5e0e4af
